CROSS-RESISTANCE OF DRUG-RESISTANT MURINE P388-LEUKEMIAS TO TAXOL INVIVO

被引:17
|
作者
WAUD, WR
GILBERT, KS
HARRISON, SD
GRISWOLD, DP
机构
[1] Chemotherapy and Toxicology Research, Southern Research Institute, Birmingham, 35255-5305, AL
关键词
TAXOL; CROSS RESISTANCE; P388-LEUKEMIA;
D O I
10.1007/BF00685557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The antimicrotubule agent taxol (NSC 125973) has shown clinical antitumor activity against several classically refractory tumors. We developed a drug-resistance profile for taxol using ten drug-resistant P388 leukemias to identify potentially useful guides for patient selection for further clinical trials of taxol and possible non-cross-resistant drug combinations with taxol. Multidrug-resistant P388 leukemias exhibited either clear (leukemia resistant to amsacrine) or marginal cross-resistance (leukemias resistant to doxorubicin, actinomycin D, and mitoxantrone) to taxol. Leukemias resistant to vincristine (non-multidrug-resistant leukemia), camptothecin, melphalan, cisplatin, 1-beta-D-arabinofuranosylcytosine, and methotrexate were not cross-resistant to taxol. The data suggest that (1) it may be important to exclude or to monitor with extra care patients who have previously been treated with amsacrine, doxorubicin, actinomycin D, or mitoxantrone and (2) a combination of one of the non-cross-resistant drugs and taxol might exhibit therapeutic synergism.
引用
收藏
页码:255 / 257
页数:3
相关论文
共 50 条
  • [1] CROSS-RESISTANCE OF DRUG-RESISTANT MURINE LEUKEMIAS TO DEOXYSPERGUALIN (NSC-356894) INVIVO
    HARRISON, SD
    BROCKMAN, RW
    TRADER, MW
    LASTER, WR
    GRISWOLD, DP
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (04) : 345 - 351
  • [2] ANTITUMOR DRUG CROSS-RESISTANCE INVIVO IN A CISPLATIN-RESISTANT MURINE P388 LEUKEMIA
    WAUD, WR
    HARRISON, SD
    GILBERT, KS
    LASTER, WR
    GRISWOLD, DP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 27 (06) : 456 - 463
  • [3] Lack of in vivo cross-resistance with 4′-thio-ara-C against drug-resistant murine P388 and L1210 leukemias
    William R. Waud
    Karen S. Gilbert
    John A. Secrist
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 399 - 403
  • [4] Lack of in vivo cross-resistance with 4′-thio-ara-C against drug-resistant murine P388 and L1210 leukemias
    Waud, William R.
    Gilbert, Karen S.
    Secrist, John A., III
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 399 - 403
  • [5] CROSS-RESISTANCE AND COLLATERAL SENSITIVITY OF DRUG-RESISTANT P388 AND L1210 LEUKEMIAS TO FLAVONE ACETIC-ACID (FAA, NSC 347512) INVIVO
    TRADER, MW
    HARRISON, SD
    LASTER, WR
    GRISWOLD, DP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 312 - 312
  • [6] CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE INVIVO OF A SUBLINE OF P388 LEUKEMIA RESISTANT TO ADRIAMYCIN
    JOHNSON, RK
    CHITNIS, MP
    GOLDIN, A
    PHARMACOLOGIST, 1976, 18 (02): : 173 - 173
  • [7] Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias
    Waud, WR
    Gilbert, KS
    Grindey, GB
    Worzalla, JF
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 (02) : 178 - 180
  • [8] INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA
    JOHNSON, RK
    CHITNIS, MP
    EMBREY, WM
    GREGORY, EB
    CANCER TREATMENT REPORTS, 1978, 62 (10): : 1535 - 1547
  • [9] COMPARISON OF INVIVO AND INVITRO CROSS-RESISTANCE PATTERNS FOR P388 SENSITIVE AND P388 MENOGARIL RESISTANT CELLS
    BADINER, GJ
    WILSON, DK
    LI, LH
    BHUYAN, BK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 299 - 299
  • [10] DRUG-RESISTANT LEPTOMONAS - CROSS-RESISTANCE IN TRYPANOCIDE-RESISTANT CLONES
    BACCHI, CJ
    LAMBROS, C
    ELLENBOGEN, BB
    PENKOVSKY, LN
    SULLIVAN, W
    EYINNA, EE
    HUTNER, SH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (06) : 688 - 692